Stock listing
Dusseldorf:BJX1 BioLife Solutions, Inc. Aktie
German listing (Dusseldorf) of BioLife Solutions, Inc. · home listing NASDAQ:BLFS
Follow BioLife Solutions, Inc. into a list and get an email when it puts out news.

- Ticker
- Dusseldorf:BJX1
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- Dusseldorf
- Currency
- EUR
What changed lately
Latest news release · Aug 6, 2026
BioLife Reports Second Quarter 2026 Financial Results
Latest earnings call · May 7, 2026
BioLife Solutions (NASDAQ:BLFS) Q1 2026 Earnings Call
Replay and transcript
Latest deck · Jul 22, 2026
Merger or Acquisition (July 2026)
Merger or acquisition · 9 slides
Latest news
BioLife Solutions, Inc. on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 8 in the last 12 months · 153 in all · newest Aug 6, 2026 · oldest 2019
- Calls
- 23 calls with a replay · 23 with a transcript · latest May 7, 2026
- Decks
- 11 decks · latest Jul 22, 2026
Where BioLife Solutions, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:BLFS · Home listing | NASDAQ | United States | USD |
| LS Exchange:A1XCF2 | LS Exchange | Germany | EUR |
| Lang & Schwarz:A1XCF2 | Lang & Schwarz | Germany | EUR |
| gettex:BJX1 | gettex | Germany | EUR |
| Dusseldorf:BJX1 · This page | Dusseldorf | Germany | EUR |
| Frankfurt:BJX1 | Frankfurt | Germany | EUR |
| Stuttgart:BJX1 | Stuttgart | Germany | EUR |
| Tradegate:BJX1 | Tradegate | Germany | EUR |
| BOATS:BLFS | BOATS | United States | USD |
Valuation
- Enterprise value
- No market cap
- P/E
- No market cap
- EV/sales
- No market cap
- EV/EBITDA
- No market cap
- Price/book
- No market cap
- Gross margin
- No statements on 6ix yet
- Operating margin
- No statements on 6ix yet
- Net margin
- No statements on 6ix yet
- Debt to equity
- No statements on 6ix yet
- Beta vs S&P 500
- 1.07
Team and board
Officers
| Officer | Role |
|---|---|
| Rod de Greef | Chairman & Chief Executive Officer |
| Troy Wichterman | Chief Financial Officer |
| John Graziano | Investor Relations |
| Aby J. Mathew | Executive Vice President and Chief Scientific Officer |
| Sean Werner | Chief Technology Officer |
| Todd Berard | Chief Commercial Officer |
| Tony Hunt | Executive Chairman |
Board
| Director | Role |
|---|---|
| Rod de Greef | Chairman & Chief Executive Officer |
| Tony Hunt | Executive Chairman |
| Cathy Coste | Director and Audit Committee Chair |
| Joydeep Goswami | Director |
Events
| Call | When | Status |
|---|---|---|
| BioLife Solutions (NASDAQ:BLFS) Q1 2026 Earnings Call | Thu, May 07, 2026 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q4 2025 Earnings Call | Thu, Feb 26, 2026 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q2 2025 Earnings Call | Thu, Aug 07, 2025 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q1 2025 Earnings Call | Thu, May 08, 2025 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q4 2024 Earnings Call | Mon, Feb 10, 2025 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q3 2024 Earnings Call | Tue, Nov 12, 2024 · 1:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q1 2024 Earnings Call | Thu, May 09, 2024 · 4:30 PM ET | Replay |
| BioLife Solutions (NASDAQ:BLFS) Q4 2023 Earnings Call | Thu, Feb 29, 2024 · 4:30 PM ET | Replay |
All 23 calls
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Merger or Acquisition (July 2026) | Merger or acquisition | 9 slides | Jul 22, 2026 |
| Investor Presentation (June 2026) | Investor deck | 28 slides | Jun 3, 2026 |
| Investor Presentation (March 2026) | Investor deck | 28 slides | Mar 2, 2026 |
| Investor Presentation (November 2025) | Investor deck | 28 slides | Nov 17, 2025 |
| Proxy Contest (July 2024) | Proxy contest | 8 slides | Jul 26, 2024 |
| Investor Presentation (August 2023) | Investor deck | 54 slides | Aug 31, 2023 |
| Investor Presentation (February 2018) | Investor deck | 25 slides | Feb 12, 2018 |
| Investor Presentation (February 2017) | Investor deck | 43 slides | Feb 16, 2017 |
| OneMed Forum (January 2015) | Conference | 46 slides | January 2015 |
| Investor Presentation (May 2012) | Investor deck | 18 slides | May 2012 |
All 11 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2011) | Investor deck | 19 slides | Oct 21, 2011 |
Cap table
Built by 6ix from BioLife Solutions, Inc.’s releases
- Common shares
- 48,889,090
- Fully diluted
- 48,889,090
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 48,889,090 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 48,889,090 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Raymond W. Cohen Other companies: InspireMD Inc. (Director · Since at least Jul 31, 2025); RxSight, Inc. (Director · Since at least Jul 31, 2025); Kestra Medical Technologies, Ltd. (Director · Since at least Mar 6, 2025); Axonics Modulation Technologies Inc (Chief Executive Officer, Director · Oct 30, 2018 – Jan 31, 2021 · Past); Spectrum Pharmaceuticals Inc (Director · Jun 27, 2016 – Jun 20, 2019 · Past) | Director · Jan 13, 2017 – Jul 12, 2021 · Past |
| Timothy L Moore Other companies: Cerus Corporation (Director · Since at least Sep 5, 2018); Allogene Therapeutics, Inc. (Chief Technical Officer · Apr 24, 2023 – Feb 3, 2025 · Past); Instil Bio, Inc. (Chief Operating Officer · Sep 6, 2022 – Sep 6, 2022 · Past); Kite Pharma Inc (EVP, Technical Operations · Mar 15, 2016 – Oct 3, 2017 · Past) | Director · Since at least Sep 1, 2022 |
| Catherine Coste Other companies: Renalytix PLC (Director · Since at least Jul 1, 2023); Minerva Surgical, Inc. (Director · Oct 21, 2021 – Jun 10, 2022 · Past); Biomerica, Inc. (Director · Oct 26, 2020 – Dec 13, 2024 · Past) | Director · Since at least Mar 18, 2025 |
| Rachel Ellingson Other companies: Solventum Corporation (Chief Strategy & Corporate Development Officer · Since at least Nov 5, 2026); Zimmer Biomet Holdings, Inc. (Chief Administrative Officer · Jan 4, 2021 – Feb 20, 2025 · Past); St. Jude Medical Inc (VP, Global Communications · Aug 30, 2012 – Jan 4, 2017 · Past) | Director · Since at least Apr 1, 2021 |
| Tony Hunt Other companies: 908 Devices Inc. (Director · Since at least Mar 2, 2022); Repligen Corporation (Director · Since at least Nov 19, 2020) | Director · Since at least Dec 20, 2024 |
| Aby J. Mathew | Executive Vice President and Chief Scientific Officer · Since at least Aug 10, 2012 |
| Amy DuRoss | Director · Since at least May 6, 2022 |
| Andrew G Hinson | Director · Jan 13, 2017 – Aug 16, 2021 · Past |
| Cathy Coste | Director and Audit Committee Chair · Since at least Mar 18, 2025 |
| Dusty Tenney | COO and President · May 3, 2021 – May 3, 2021 · Past |
All 27 people
| Person | Seat |
|---|---|
| Garrie Richardson | Chief Revenue Officer · Oct 19, 2023 – Sep 16, 2024 · Past |
| Geraint Phillips | SVP, Global Operations · Jan 3, 2023 – Mar 8, 2024 · Past |
| Howard S Breslow | Director · Feb 27, 2009 – May 10, 2012 · Past |
| Joe Annicchiarico | Chief Operating Officer · Aug 10, 2012 – May 4, 2015 · Past |
| John Graziano | Investor Relations · Since at least Aug 6, 2026 |
| Joseph C Schick | Director · Nov 18, 2013 – Mar 8, 2024 · Past |
| Joydeep Goswami | Director · Since at least Mar 18, 2025 |
| Karen A Foster | Chief Quality and Operations · Since at least Sep 29, 2020 |
| Matt Snyder | Vice President, Global Sales · Oct 17, 2006 – Mar 15, 2016 · Past |
| Rod de Greef | Chairman & Chief Executive Officer · Since at least Nov 4, 2026 |
| Roderick De Greef | Chief Executive Officer, Director · Since at least Jun 18, 2026 |
| Sarah Aebersold | Chief Human Resources Officer · Since at least Apr 1, 2025 |
| Sean Werner | Chief Technology Officer · Since at least Dec 2, 2024 |
| Thomas Girschweiler | Director · Feb 11, 2011 – Nov 24, 2020 · Past |
| Tim Moore | Since at least Oct 8, 2026 |
| Todd Berard | Chief Marketing Officer · Since at least Sep 28, 2023 |
| Troy Wichterman | Chief Financial Officer · Since at least Nov 4, 2021 |
Log in to ask 6ix AI your own questions about BioLife Solutions, Inc.